연구개발
글로벌 유전자·세포치료제 개발을 선도하는 바이오 혁신기업
핵심기술
Genetically modified MSCs are supplied in a frozen, allogeneic formulation in a large quantities.
- Wound/tumor trophic MSCs
- MSCs/genes act as bioreactors in vivo
- One-time introduction of multiple genes for MCB
- Equipped with a safety gene for controlling SAE
- Overcoming the limitation of in vivo delivery of gene therapy
- First-in-Class
- Allogenic, Frozen, Off-the-Shelf
- Easy scale-up of Master Cell Bank
- A large quantity of Homogeneous Cells
